211 related articles for article (PubMed ID: 15020036)
1. The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.
Golomb BA; Criqui MH; White HL; Dimsdale JE
Control Clin Trials; 2004 Apr; 25(2):178-202. PubMed ID: 15020036
[TBL] [Abstract][Full Text] [Related]
2. Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.
Golomb BA; Dimsdale JE; Koslik HJ; Evans MA; Lu X; Rossi S; Mills PJ; White HL; Criqui MH
PLoS One; 2015; 10(7):e0124451. PubMed ID: 26132393
[TBL] [Abstract][Full Text] [Related]
3. Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.
Golomb BA; Criqui MH; White H; Dimsdale JE
Arch Intern Med; 2004 Jan; 164(2):153-62. PubMed ID: 14744838
[TBL] [Abstract][Full Text] [Related]
4. A clinical trial to evaluate the effect of statin use on lowering aldosterone levels.
Hornik ES; Altman-Merino AE; Koefoed AW; Meyer KM; Stone IB; Green JA; Williams GH; Adler GK; Williams JS
BMC Endocr Disord; 2020 Jul; 20(1):105. PubMed ID: 32664962
[TBL] [Abstract][Full Text] [Related]
5. Response to The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes".
Antuono P
Contemp Clin Trials; 2005 Jun; 26(3):417-8. PubMed ID: 15869908
[No Abstract] [Full Text] [Related]
6. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
7. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE
JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718
[TBL] [Abstract][Full Text] [Related]
8. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
9. Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.
Golomb BA; Dimsdale JE; White HL; Ritchie JB; Criqui MH
Arch Intern Med; 2008 Apr; 168(7):721-7. PubMed ID: 18413554
[TBL] [Abstract][Full Text] [Related]
10. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
12. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
14. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
15. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.
Rojas-Fernandez CH; Cameron JC
Ann Pharmacother; 2012 Apr; 46(4):549-57. PubMed ID: 22474137
[TBL] [Abstract][Full Text] [Related]
16. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
17. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
Albert MA; Staggers J; Chew P; Ridker PM;
Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301
[TBL] [Abstract][Full Text] [Related]
18. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial.
Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R
Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294
[TBL] [Abstract][Full Text] [Related]
19. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series.
Cham S; Koslik HJ; Golomb BA
Drug Saf Case Rep; 2016 Dec; 3(1):1. PubMed ID: 27747681
[TBL] [Abstract][Full Text] [Related]
20. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Kazerooni R; Watanabe JH; Bounthavong M
Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
